Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by ORIC Pharmaceuticals ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences August 26, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Updates August 12, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Keith Lui as Senior Vice President of Commercial and Medical Affairs August 05, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) August 02, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Announces Multiple Clinical Collaborations with Strategic Partners to Support Ongoing Trial Evaluating ORIC-944 in Combination with AR Inhibitors for the Treatment of Prostate Cancer July 16, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) July 05, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) June 07, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences May 29, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates May 06, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) May 03, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC April 15, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting April 08, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) April 05, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences April 04, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates March 11, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference March 06, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting March 05, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) March 01, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit February 14, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) February 02, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences January 31, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Announces $125 Million Private Placement Financing January 22, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Provides Initial Phase 1b Data for ORIC-944, Operational Highlights for 2023, and Anticipated Upcoming Milestones January 08, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 02, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC Initial Phase 1 Dose Escalation Data for ORIC-533 in Relapsed/Refractory Multiple Myeloma Demonstrates Clinical Activity and Strong Safety Profile Supporting Potential for Combination Development December 11, 2023 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) December 01, 2023 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences November 09, 2023 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates November 06, 2023 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) November 03, 2023 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC-533 in Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting November 02, 2023 From ORIC Pharmaceuticals Via GlobeNewswire Tickers ORIC Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.